Literature DB >> 19690811

Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering.

Ziyad S Haidar1, Reggie C Hamdy, Maryam Tabrizian.   

Abstract

Localized and release-controlled delivery systems for the sustained expression of the biologic potency of rhBMPs are essential. A substantial number of biomaterials have been investigated thus far. Most fail after implantation or administration mainly due to either being too soft, difficult to control and/or stabilize mechanically. In the second part of this review, we review a representative selection of rhBMP-2 and rhBMP-7 carrier materials and delivery systems ranging from simple nano/microparticles to complex 3-D scaffolds in sites of orthopaedic and craniofacial bone regeneration and repair.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19690811     DOI: 10.1007/s10529-009-0100-8

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  47 in total

1.  Injectable thermogelling chitosan for the local delivery of bone morphogenetic protein.

Authors:  Shaun W McLaughlin; Zhanwu Cui; Trevor Starnes; Cato T Laurencin; Ho-Man Kan; Qian Wu; Lakshmi S Nair
Journal:  J Mater Sci Mater Med       Date:  2012-06-03       Impact factor: 3.896

2.  Bone Morphogenetic Protein-9-Stimulated Adipocyte-Derived Mesenchymal Progenitors Entrapped in a Thermoresponsive Nanocomposite Scaffold Facilitate Cranial Defect Repair.

Authors:  Cody S Lee; Elliot S Bishop; Zari Dumanian; Chen Zhao; Dongzhe Song; Fugui Zhang; Yunxiao Zhu; Guillermo A Ameer; Tong-Chuan He; Russell R Reid
Journal:  J Craniofac Surg       Date:  2019-09       Impact factor: 1.046

Review 3.  Clinical application of bone morphogenetic proteins for bone healing: a systematic review.

Authors:  Gopal Shankar Krishnakumar; Alice Roffi; Davide Reale; Elizaveta Kon; Giuseppe Filardo
Journal:  Int Orthop       Date:  2017-04-19       Impact factor: 3.075

Review 4.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-02-19       Impact factor: 6.389

Review 5.  Biomimetic coatings for bone tissue engineering of critical-sized defects.

Authors:  Yuelian Liu; Gang Wu; Klaas de Groot
Journal:  J R Soc Interface       Date:  2010-05-19       Impact factor: 4.118

6.  Cell-based gene therapy for repair of critical size defects in the rat fibula.

Authors:  Zawaunyka W Lazard; Michael H Heggeness; John A Hipp; Corinne Sonnet; Angie S Fuentes; Rita P Nistal; Alan R Davis; Ronke M Olabisi; Jennifer L West; Elizabeth A Olmsted-Davis
Journal:  J Cell Biochem       Date:  2011-06       Impact factor: 4.429

7.  Functionalization of PCL-3D Electrospun Nanofibrous Scaffolds for Improved BMP2-Induced Bone Formation.

Authors:  Jacob M Miszuk; Tao Xu; Qingqing Yao; Fang Fang; Josh D Childs; Zhongkui Hong; Jianning Tao; Hao Fong; Hongli Sun
Journal:  Appl Mater Today       Date:  2017-12-14

8.  Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds.

Authors:  Sungsoo S Lee; Brian J Huang; Stuart R Kaltz; Shantanu Sur; Christina J Newcomb; Stuart R Stock; Ramille N Shah; Samuel I Stupp
Journal:  Biomaterials       Date:  2012-10-23       Impact factor: 12.479

9.  Secondary structure of rhBMP-2 in a protective biopolymeric carrier material.

Authors:  Flora Gilde; Ofélia Maniti; Raphael Guillot; Joao F Mano; Delphine Logeart-Avramoglou; Frédéric Sailhan; Catherine Picart
Journal:  Biomacromolecules       Date:  2012-10-01       Impact factor: 6.988

10.  Bone morphogenic protein-2 (BMP-2) loaded hybrid coating on porous hydroxyapatite scaffolds for bone tissue engineering.

Authors:  Shin-Hee Jun; Eun-Jung Lee; Tae-Sik Jang; Hyoun-Ee Kim; Jun-Hyeog Jang; Young-Hag Koh
Journal:  J Mater Sci Mater Med       Date:  2013-01-24       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.